Cerus Corporation Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 49.25. In total, the insiders bought 2 789 373 and sold 1 097 875 CERS shares in the last 100 trades.

Insider Power

(Last 100 transactions)
49.25
Buy 2 789 373 Shares
Sell 1 097 875 Shares

Historical Insider Trades

Date Type Action Person Amount
Jun 05, 2024 Common Stock Buy Witney Frank 40 000
Jun 05, 2024 Common Stock Buy Swisher Daniel N Jr 40 000
Jun 05, 2024 Common Stock Buy Shan Hua 40 000
Jun 05, 2024 Common Stock Buy Schulze Gail 40 000
Jun 05, 2024 Common Stock Buy Nachtsheim Jami K 40 000
Jun 05, 2024 Common Stock Buy Moore Timothy L. 40 000
Jun 05, 2024 Common Stock Buy Lucena Ann 40 000
Jun 05, 2024 Common Stock Buy Bjerkholt Eric 40 000
May 13, 2024 Common Stock Buy Shan Hua 2 500
May 10, 2024 Common Stock Buy Nachtsheim Jami K 2 000
May 09, 2024 Common Stock Buy Witney Frank 20 000
May 09, 2024 Common Stock Buy Swisher Daniel N Jr 2 500
Mar 14, 2024 Common Stock Sell Green Kevin Dennis 21 497
Mar 14, 2024 Common Stock Sell Jensen Chrystal 17 824
Mar 14, 2024 Common Stock Sell Jayaraman Vivek K 26 794
Mar 14, 2024 Common Stock Sell Greenman William Mariner 63 611
Mar 14, 2024 Common Stock Sell Corash Laurence M 14 360
Mar 14, 2024 Common Stock Sell Benjamin Richard J 17 738
Mar 13, 2024 Common Stock Sell Green Kevin Dennis 21 058
Mar 13, 2024 Common Stock Sell Moore Carol 10 203
Mar 13, 2024 Common Stock Sell Moore Carol 10 416
Mar 13, 2024 Common Stock Sell Jensen Chrystal 17 460
Mar 13, 2024 Common Stock Sell Jayaraman Vivek K 26 247
Mar 13, 2024 Common Stock Sell Greenman William Mariner 62 315
Mar 13, 2024 Common Stock Sell Corash Laurence M 14 067
Click to get the best stock tips daily for free!

About Cerus Corporation

Cerus Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed t... CERS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT